NCT00464698View on ClinicalTrials.gov

Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Obsessive Compulsive Disorder
Interventions
DRUG

Duloxetine

Participants received increasing amounts of Duloxetine for 7 weeks.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00464698 - Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD) | Biotech Hunter | Biotech Hunter